Literature DB >> 2200181

Dopamine receptor subtypes: beyond the D1/D2 classification.

P H Andersen1, J A Gingrich, M D Bates, A Dearry, P Falardeau, S E Senogles, M G Caron.   

Abstract

The D1/D2 dopamine receptor classification is widely accepted. However, intense investigative efforts over the last several years using pharmacological, biochemical and behavioral approaches have produced results that are increasingly difficult to reconcile with the existence of only two dopamine receptor subtypes. Recent developments, including cloning of the cDNAs and/or genes for several members of the large family of G-protein-coupled receptors, have revealed that heterogeneity in the pharmacological or biochemical characteristics of individual receptors often indicates the presence of previously unsuspected molecular subtypes. In this article, Marc Caron and colleagues have assembled the main lines of evidence that suggest the presence of several novel subtypes for both D1 and D2 dopamine receptors and predict that molecular cloning will, in the near future, confirm their existence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200181     DOI: 10.1016/0165-6147(90)90249-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  50 in total

1.  Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens.

Authors:  S M Nicola; R C Malenka
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

Review 2.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Dopamine receptor genes: new tools for molecular psychiatry.

Authors:  H B Niznik; H H Van Tol
Journal:  J Psychiatry Neurosci       Date:  1992-10       Impact factor: 6.186

4.  Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor.

Authors:  M Tiberi; K R Jarvie; C Silvia; P Falardeau; J A Gingrich; N Godinot; L Bertrand; T L Yang-Feng; R T Fremeau; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

5.  D2 dopamine receptors in the human retina: cloning of cDNA and localization of mRNA.

Authors:  A Dearry; P Falardeau; C Shores; M G Caron
Journal:  Cell Mol Neurobiol       Date:  1991-10       Impact factor: 5.046

6.  Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes.

Authors:  D K Grandy; Y A Zhang; C Bouvier; Q Y Zhou; R A Johnson; L Allen; K Buck; J R Bunzow; J Salon; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  D1 and D2 dopamine receptor mRNA in rat brain.

Authors:  D M Weiner; A I Levey; R K Sunahara; H B Niznik; B F O'Dowd; P Seeman; M R Brann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

8.  Dopamine receptor-mediated regulation of neuronal "clock" gene expression.

Authors:  M Imbesi; S Yildiz; A Dirim Arslan; R Sharma; H Manev; T Uz
Journal:  Neuroscience       Date:  2008-11-05       Impact factor: 3.590

Review 9.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

10.  Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.

Authors:  A M Deveney; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.